LPS induces pulmonary microvascular endothelial cell barrier dysfunction by upregulating ceramide production.

LPS induces pulmonary microvascular endothelial cell barrier dysfunction by upregulating ceramide production.
复制标题

DOI:
10.1016/j.cellsig.2022.110250
复制
发表时间:
2022-01
影响因子:
4.8
通讯作者:
Jianjun Jiang;Huijuan Ouyang;Qun Zhou;Sihui Tang;Pu Fang;Guofang Xie;Jin Yang;Gengyun Sun
Jianjun Jiang;Huijuan Ouyang;Qun Zhou;Sihui Tang;Pu Fang;Guofang Xie;Jin Yang;Gengyun Sun
中科院分区:
生物学2区
文献类型:
--
作者:
Jianjun Jiang;Huijuan Ouyang;Qun Zhou;Sihui Tang;Pu Fang;Guofang Xie;Jin Yang;Gengyun Sun

文献摘要

相似文献

神经酰胺在肺微血管内皮细胞(PMVEC)屏障功能障碍中的具体作用尚不清楚。在本研究中,泛半胱天冬酶抑制剂预处理显着减少LPS诱导的PMVEC凋亡,并有助于刺激PMVEC屏障重建后12小时,但在前8小时对PMVEC屏障功能障碍没有影响。进一步的研究表明,丙咪嗪,一种酸性鞘磷脂酶(ASMase)抑制剂,显着抑制LPS诱导的屏障功能障碍,而针对丝氨酸棕榈酰转移酶亚基1(SPTLC 1)的siRNA和药理学抑制剂myriocin没有抑制早期急性屏障功能障碍,但显着抑制PMVEC凋亡和凋亡依赖性延迟屏障功能障碍。此外,LPS通过诱导瞬时受体电位通道6(TRPC 6)过表达和通过ASMase/神经酰胺途径的钙内流来激活RhoA,并且RhoA的激活进一步诱导PMVEC的细胞骨架重排和细胞间连接的破坏,最终导致早期急性PMVEC屏障功能障碍。然而,关于凋亡依赖性迟发性屏障功能障碍,在细胞旁细胞中神经酰胺诱导的从头合成途径诱导PMVEC凋亡,其中Txnip过表达抑制Trx活性,随后在LPS诱导的PMVEC凋亡的背景下激活ASK 1,作用于神经酰胺诱导的p38 MAPK和JNK激活的上游。同时,在LPS或外源性C8神经酰胺诱导的大鼠ALI中,神经酰胺通过诱导Txnip/TRX/ASK 1/P38和JNK通路在肺损伤中发挥重要作用。因此,Txnip/TRX/ASK 1/p38和JNK通路可能参与了LPS诱导的ALI中神经酰胺介导的PMVEC凋亡。
The specific role of ceramides in pulmonary microvascular endothelial cell (PMVEC) barrier dysfunction remains unclear. In the present study, pretreatment with pan-caspase inhibitors significantly reduced LPS-induced PMVEC apoptosis and helped to stimulate PMVEC barrier reconstruction after 12 h but had no effect on PMVEC barrier dysfunction in the first 8 h. Further studies showed that imipramine, an acid sphingomyelinase (ASMase) inhibitor, significantly inhibited LPS-induced barrier dysfunction, while an siRNA targeting serine palmityl transferase subunit 1 (SPTLC1) and the pharmacological inhibitor myriocin did not inhibit early acute barrier dysfunction but significantly inhibited PMVEC apoptosis and apoptosis-dependent delayed barrier dysfunction. In addition, LPS was shown to activate RhoA by inducing transient receptor potential channel 6 (TRPC6) overexpression and calcium influx through the ASMase/ceramide pathway, and activation of RhoA further induced the cytoskeletal rearrangement of PMVECs and destruction of intercellular junctions, ultimately leading to early acute PMVEC barrier dysfunction. However, regarding apoptosis-dependent delayed barrier dysfunction, the ceramide-induced de novo synthesis pathway in paracellular cells induced the apoptosis of PMVECs, in which Txnip overexpression inhibited Trx activity and subsequently activated ASK1 in the context of LPS-induced PMVEC apoptosis, acting upstream of the ceramide-induced activation of p38 MAPK and JNK. At the same time, in rats with LPS- or exogenous C8 ceramide-induced ALI, ceramide was demonstrated to play an important role in lung injury by inducing the Txnip/TRX/ASK1/P38 and JNK pathways. Thus, the Txnip/TRX/ASK1/p38 and JNK pathways might be involved in ceramide-mediated PMVEC apoptosis in LPS-induced ALI.